|Description||Artificial Heart Manufacturer|
|Series B, 5/2004 ||$3.7M|
|Series D, 6/2009 |
Highway 12 Ventures
|Partial Close, 3/2011 ||$4.99M|
|Venture Round, 3/2013 ||$4M|
|Venture Round, 12/2013 ||$14M|
|Debt, 3/2013 |
Athyrium Opportunities Fund
SynCardia Systems, Inc. is the manufacturer of the CardioWestâ„¢ temporary Total Artificial Heart (TAHâ€‘t).
It is the only FDA and CE approved temporary Total Artificial Heart in the world.
It is designed for severely ill patients with end-stage biventricular failure.
The TAHâ€‘t serves as a bridge to human heart transplant for transplant eligible patients who are within days or even hours of death.